The name change to Flyte Aviation and reincorporation to Nevada suggest a strategic pivot away from the catheter business. Monitor for a business combination or asset sale in the aviation sector. The heavy authorized-but-unissued share count (500M common shares) and multiple active S-1/S-3 registration statements signal high future dilution risk. The reverse split alone does not fix the underlying business — watch for the next 10-Q to assess cash burn and revenue trajectory.
Price Chart
Executive Summary
Catheter Precision, Inc. filed an 8-K reporting stockholder approval of a 1-for-10 reverse stock split, a name change to Flyte Aviation, Inc., a new ticker symbol VJET, a reincorporation from Delaware to Nevada, an increase in the 2023 Equity Incentive Plan by 5,000,000 shares, a one-time repricing of underwater stock options to $0.152/share, and authorization to reduce the Series J conversion price floor to $0.23. The reverse split and name change become effective October 5, 2026, reducing outstanding shares from ~21.0M to ~2.1M. These actions are classic distressed-company recapitalization steps — the reverse split and reincorporation signal a pivot away from the legacy med-tech business, while the equity plan increase and option repricing are retention tools. No financial results are reported, so the filing is neutral on fundamentals but structurally significant.
Key Facts
- 1-for-10 reverse stock split effective October 5, 2026; outstanding shares reduce from ~21,019,874 to ~2,101,987
- Company name changes from Catheter Precision, Inc. to Flyte Aviation, Inc.; new ticker symbol VJET
- Reincorporation from Delaware to Nevada approved by stockholders
- 2023 Equity Incentive Plan increased by 5,000,000 shares
- One-time repricing of underwater stock options to $0.152/share (pre-split); CEO Jenkins holds options on 89,999 shares, CFO Anderson on 66,315 shares
- Series J Convertible Preferred Stock conversion price floor authorized to be reduced to as low as $0.23/share
- Issuance of up to 340,000 shares upon exercise of Series M Common Stock Purchase Warrants approved
- David A. Jenkins re-elected as Class II director
- WithumSmith+Brown, PC ratified as independent auditor for FY 2027
Financial Impact
Reverse stock split reduces share count by 90% from ~21.0M to ~2.1M; no cash impact. Option repricing reduces exercise price to $0.152/share (pre-split), lowering future dilution cost. Equity plan adds 5M shares (pre-split) of potential dilution. Series J conversion price floor reduction to $0.23/share increases potential dilution from preferred conversion.
Risk Factors
- Reverse stock split may not prevent delisting if the stock price subsequently declines below NYSE American continued listing standards
- Massive authorized share count (500M) and multiple shelf registrations create persistent dilution overhang
- Reincorporation to Nevada may reduce shareholder protections and could precede a distressed transaction
- No financial results in this filing — the company's operating performance and cash position remain unknown
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-031895 |
| Exhibit: ex_1021735.htm | 0001437749-26-031895 |
| Document: 0001437749-26-031895-index-headers.html | 0001437749-26-031895 |
| Document: 0001437749-26-031895-index.html | 0001437749-26-031895 |
| Document: 0001437749-26-031895.txt | 0001437749-26-031895 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 29d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 11w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 12w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers